South Korea
# |
Name |
Inventory |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.34 B
|
Dec. 31, 2023 | USD 119.86 | -2.20% |
|
South Korea |
|
2 |
USD 2.03 B
|
Dec. 31, 2023 | USD 745.69 | 1.15% |
|
South Korea |
|
3 |
USD 445.23 M
|
Dec. 31, 2023 | USD 9.61 | -3.70% |
|
South Korea |
|
4 |
USD 396.48 M
|
Dec. 31, 2023 | USD 88.80 | -5.65% |
|
South Korea |
|
5 |
USD 270.60 M
|
Dec. 31, 2023 | USD 13.69 | -2.57% |
|
South Korea |
|
6 |
USD 221.81 M
|
Dec. 31, 2023 | USD 159.35 | -4.24% |
|
South Korea |
|
7 |
USD 218.69 M
|
Dec. 31, 2023 | USD 83.97 | -5.00% |
|
South Korea |
|
8 |
USD 200.78 M
|
Dec. 31, 2023 | USD 56.39 | -4.53% |
|
South Korea |
|
9 |
USD 185.51 M
|
Dec. 31, 2023 | USD 89.76 | -4.42% |
|
South Korea |
|
10 |
USD 150.24 M
|
Dec. 31, 2023 | USD 8.02 | 4.65% |
|
South Korea |
|
11 |
USD 149.58 M
|
Dec. 31, 2023 | USD 31.05 | -1.12% |
|
South Korea |
|
12 |
USD 145.77 M
|
Dec. 31, 2023 | USD 6.82 | -1.91% |
|
South Korea |
|
13 |
USD 144.88 M
|
Dec. 31, 2023 | USD 3.69 | -1.06% |
|
South Korea |
|
14 |
USD 106.25 M
|
Dec. 31, 2023 | USD 9.85 | -4.50% |
|
South Korea |
|
15 |
USD 105.71 M
|
Dec. 31, 2023 | USD 15.77 | -2.26% |
|
South Korea |
|
16 |
USD 93.56 M
|
Dec. 31, 2023 | USD 23.36 | -2.28% |
|
South Korea |
|
17 |
USD 92.73 M
|
Dec. 31, 2023 | USD 54.68 | -7.62% |
|
South Korea |
|
18 |
USD 90.51 M
|
Dec. 31, 2023 | USD 65.38 | -0.04% |
|
South Korea |
|
19 |
USD 89.33 M
|
Dec. 31, 2023 | USD 33.57 | -2.13% |
|
South Korea |
|
20 |
USD 85.96 M
|
Dec. 31, 2023 | USD 12.66 | -2.66% |
|
South Korea |
|
21 |
USD 81.48 M
|
Dec. 31, 2023 | USD 15.49 | -2.92% |
|
South Korea |
|
22 |
USD 80.70 M
|
Dec. 31, 2023 | USD 9.80 | -1.72% |
|
South Korea |
|
23 |
USD 80.54 M
|
Dec. 31, 2023 | USD 18.22 | -3.57% |
|
South Korea |
|
24 |
USD 78.74 M
|
Dec. 31, 2023 | USD 70.28 | -5.55% |
|
South Korea |
|
25 |
USD 77.12 M
|
Dec. 31, 2023 | USD 34.59 | -4.65% |
|
South Korea |
|
26 |
USD 72.55 M
|
Dec. 31, 2023 | USD 7.87 | -2.10% |
|
South Korea |
|
27 |
USD 62.91 M
|
Dec. 31, 2023 | USD 5.23 | -2.06% |
|
South Korea |
|
28 |
USD 61.94 M
|
Dec. 31, 2023 | USD 32.21 | -3.61% |
|
South Korea |
|
29 |
USD 61.13 M
|
Dec. 31, 2023 | USD 11.62 | -0.90% |
|
South Korea |
|
30 |
USD 54.30 M
|
Dec. 31, 2023 | USD 4.07 | -1.95% |
|
South Korea |
|
31 |
USD 53.06 M
|
Dec. 31, 2023 | USD 14.37 | -3.79% |
|
South Korea |
|
32 |
USD 47.61 M
|
Dec. 31, 2023 | USD 1.37 | -0.64% |
|
South Korea |
|
33 |
USD 47.40 M
|
Dec. 31, 2023 | USD 7.33 | -4.07% |
|
South Korea |
|
34 |
USD 45.79 M
|
Dec. 31, 2023 | USD 77.77 | -3.69% |
|
South Korea |
|
35 |
USD 43.65 M
|
Dec. 31, 2023 | USD 3.10 | -3.13% |
|
South Korea |
|
36 |
USD 41.52 M
|
Dec. 31, 2023 | USD 7.90 | -1.67% |
|
South Korea |
|
37 |
USD 41.41 M
|
Dec. 31, 2023 | USD 6.88 | -1.99% |
|
South Korea |
|
38 |
USD 36.96 M
|
Dec. 31, 2023 | USD 0.50 | -4.09% |
|
South Korea |
|
39 |
USD 35.55 M
|
Dec. 31, 2023 | USD 15.36 | -2.10% |
|
South Korea |
|
40 |
USD 33.91 M
|
Dec. 31, 2023 | USD 3.01 | -3.95% |
|
South Korea |
|
41 |
USD 31.76 M
|
Dec. 31, 2023 | USD 11.53 | -7.22% |
|
South Korea |
|
42 |
USD 27.02 M
|
Dec. 31, 2023 | USD 8.44 | -2.89% |
|
South Korea |
|
43 |
USD 24.97 M
|
Dec. 31, 2023 | USD 8.58 | -5.12% |
|
South Korea |
|
44 |
USD 24.27 M
|
Dec. 31, 2023 | USD 11.00 | -3.03% |
|
South Korea |
|
45 |
USD 23.99 M
|
Dec. 31, 2023 | USD 10.66 | -1.34% |
|
South Korea |
|
46 |
USD 23.26 M
|
Dec. 31, 2023 | USD 1.12 | -3.94% |
|
South Korea |
|
47 |
USD 22.59 M
|
Dec. 31, 2023 | USD 16.51 | 0.47% |
|
South Korea |
|
48 |
USD 19.96 M
|
Dec. 31, 2023 | USD 9.81 | -0.42% |
|
South Korea |
|
49 |
USD 19.95 M
|
Dec. 31, 2023 | USD 11.86 | -0.20% |
|
South Korea |
|
50 |
USD 16.31 M
|
Dec. 31, 2023 | USD 3.25 | -3.09% |
|
South Korea |
The Healthcare company in South Korea with the highest Inventory is Celltrion, Inc. (KSE: 068270.KS) at USD 2.34 B.
The Healthcare company in South Korea with the lowest Inventory is MedPacto, Inc. (KOSDAQ: 235980.KQ) at USD -0.29.
The top 10 Healthcare companies in South Korea by Inventory are Celltrion, Inc., Samsung Biologics Co.,Ltd., Green Cross Holdings Corporation, Green Cross Corporation, Daewoong Co., Ltd., Hanmi Pharm. Co., Ltd., Yuhan Corporation, Chong Kun Dang Pharmaceutical Corp., Daewoong pharmaceutical Co.,Ltd and SD BioSensor, Inc.
The bottom 10 Healthcare companies in South Korea by Inventory are MedPacto, Inc., Cellid, Co., Ltd., ABL Bio Inc., Peptron, Inc., RSUPPORT Co., Ltd., OliX Pharmaceuticals,Inc, Gencurix Inc., Helixmith Co., Ltd, iNtRON Biotechnology, Inc. and ALTEOGEN Inc..